Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Mijlpalen voor betere pijnzorg in Nederland
apr 2017
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen